APA (7th ed.) Citation

Hemme, E., Depuydt, M. A., van Santbrink, P. J., Wezel, A., Smeets, H. J., Foks, A. C., . . . Bot, I. (2024). Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr−/− mice. European journal of pharmacology, 985, 177121. https://doi.org/10.1016/j.ejphar.2024.177121

Chicago Style (17th ed.) Citation

Hemme, Esmeralda, Marie A.C Depuydt, Peter J. van Santbrink, Anouk Wezel, Harm J. Smeets, Amanda C. Foks, Johan Kuiper, and Ilze Bot. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology 985 (2024): 177121. https://doi.org/10.1016/j.ejphar.2024.177121.

MLA (9th ed.) Citation

Hemme, Esmeralda, et al. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology, vol. 985, 2024, p. 177121, https://doi.org/10.1016/j.ejphar.2024.177121.